SPEAKER: Eric M. Reiman, MD | CEO, Banner Research, and Executive Director, Banner Alzheimer’s Institute – Banner Health; and Director, Arizona Alzheimer's Consortium
TOPIC: “Brain Imaging, Genetics and the Prevention of Alzheimer's Disease”
Wednesday, Feb. 20
4 - 5 p.m.
MRB Room 102
- REFRESHMENTS PROVIDED -
CME CREDIT IS AVAILABLE for Genetics and Genomics Grand Rounds.
For more information, please visit: https://precisionhealth.uahs.arizona.edu/genetics-genomics-grand-rounds
Livestream available at: https://bit.ly/2MQ0qaj
Speaker Host: Dr. Linda Restifo | email@example.com
What will it take to find and support the approval and availability of an Alzheimer’s prevention therapy before 2025? In this presentation, Eric Reiman will describe the strategy he and his Alzheimer’s Prevention Initiative (API) colleagues have introduced to accelerate the evaluation of prevention therapies in persons who, based on their genetic background or biomarker findings are at increased risk for Alzheimer’s disease. He will discuss how the study of mutation carriers and non-carriers from the world’s largest early-onset autosomal dominant Alzheimer’s disease kindred, the study of persons at three levels of genetic risk for developing Alzheimer’s at older ages, and other studies have enabled them to detect and track Alzheimer’s starting many years before the onset of symptoms, launch a new era of Alzheimer’s prevention research, and contribute to the scientific understanding of this terrible disorder. Dr. Reiman is a recipient of the Potamkin Prize, which has been described as the Nobel Prize in Alzheimer’s research.
Contact: Kathy Ben | firstname.lastname@example.org
Medical Research Building, Room 102
University of Arizona Health Sciences Campus
1656 E. Mabel St.
Tucson, AZ 85721